<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850"><gtr:id>5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850</gtr:id><gtr:name>University of Strathclyde</gtr:name><gtr:address><gtr:line1>16 Richmond Street</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G1 1XQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A9426E3-7F35-48FC-BD72-3776C8F90A4A"><gtr:id>4A9426E3-7F35-48FC-BD72-3776C8F90A4A</gtr:id><gtr:name>Grants Admin Office</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:department>Medicine Dentistry and Biomedical Sci</gtr:department><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850"><gtr:id>5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850</gtr:id><gtr:name>University of Strathclyde</gtr:name><gtr:address><gtr:line1>16 Richmond Street</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G1 1XQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A9426E3-7F35-48FC-BD72-3776C8F90A4A"><gtr:id>4A9426E3-7F35-48FC-BD72-3776C8F90A4A</gtr:id><gtr:name>Grants Admin Office</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/68AA383F-F610-4850-A51A-13A390924361"><gtr:id>68AA383F-F610-4850-A51A-13A390924361</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Grieve</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0601215"><gtr:id>313136BA-6CD1-4496-BA1C-649E0BABE7E0</gtr:id><gtr:title>Role of peroxisome proliferator-activated receptor-alpha and NADPH oxidases in hypertensive cardiac remodeling</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0601215</gtr:grantReference><gtr:abstractText>Despite major improvements in treatment, heart failure remains a leading cause of mortality in the western world. Over 30,000 new cases of heart failure are diagnosed each year in the UK alone and its incidence is set to rapidly increase over the next few years. One of the principal causes of heart failure is high blood pressure, which if elevated over a prolonged period of time, results in enlargement of the heart or left ventricular hypertrophy. This process initially compensates for increased blood pressure and allows the heart to continue functioning normally. However, as left ventricular hypertrophy progresses the heart is increasingly unable to maintain normal function, which eventually leads to heart failure. Recent research has suggested that both an enzyme called NADPH oxidase, which generates toxic chemicals called reactive oxygen species, and a protein known as peroxisome proliferator-activated receptor (PPAR)-alpha, may be involved in controlling the changes that occur in the hearts of patients with high blood pressure. The aim of this project is to study the interaction between NADPH oxidase and PPAR-alpha during the development of left ventricular hypertrophy and heart failure. Experiments will be undertaken in genetically-modified mice and in experimental animal models which mimic the human disease condition. Sophisticated laboratory techniques will be used to study how changes that occur in cells may cause alterations in the structure and function of the whole heart. It is hoped that the results of this project will greatly increase our understanding of the mechanisms that are involved in the development of heart failure. This research may therefore be beneficial in helping to develop new and improved drugs for the treatment of patients with high blood pressure and heart disease.</gtr:abstractText><gtr:technicalSummary>Despite major advances in treatment, chronic heart failure remains one of the leading causes of mortality and morbidity in the western world. Its incidence is rapidly increasing and it carries a poor prognosis. One of the main underlying causes of heart failure is chronic hypertension which leads to the development of left ventricular hypertrophy (LVH). LVH is typically characterised by alterations in the extracellular matrix and in cardiomyocyte biology, which are initially adaptive in maintaining contractile function. However, progressive LVH leads to chamber dilatation, contractile dysfunction and ultimately congestive heart failure, by the collective process of cardiac remodeling. Recent work from our laboratory has suggested an essential role for NADPH oxidase-derived reactive oxygen species in the processes underlying hypertensive cardiac remodeling, specifically in the development of interstitial fibrosis, myocyte hypertrophy and contractile dysfunction. Accumulating evidence also suggests that deactivation of peroxisome proliferator-activated receptor (PPAR)-alpha, which has an established role in the regulation of myocardial metabolism, may be pivotal in the same processes which underlie the development of LVH. Interestingly, there is increasing data to support a potential interaction between PPAR-alpha and NADPH oxidases as an important component in overall regulation of the hypertrophic phenotype. The proposed project aims to (1) study the role of NADPH oxidase-derived reactive oxygen species and PPAR-alpha in normal regulation of cardiac structure and function (2) investigate how NADPH oxidase and PPAR-alpha may together influence myocyte biology and extracellular matrix structure (3) evaluate whether inhibition of NADPH oxidase and/or reactivation of PPAR-alpha can reduce cardiac remodeling. In order to specifically address the role of PPAR-alpha and NADPH oxidase in the remodeling process, experiments will be undertaken in PPAR-alpha-/- and Nox2-/- mice and in double knockouts generated by crossing these two strains. Studies will be performed in both normal mice and in those subjected to chronic pressure overload. Assessment of cardiac NADPH oxidase and PPAR activity/expression and interstitial fibrosis and will be correlated to changes in left ventricular structure and function, both by echocardiography and invasive assessment of pressure-volume relations. The results of this project should help to establish the significance of interaction between PPAR-alpha and NADPH oxidases in overall regulation of the hypertrophic phenotype. A detailed understanding of their involvement in the processes underlying cardiac remodeling may be beneficial in the development of improved strategies for the treatment of human cardiac disease.</gtr:technicalSummary><gtr:fund><gtr:end>2010-12-04</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-11-05</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>360157</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Medicine KCL</gtr:department><gtr:description>Cardiovascular Division, King's College London</gtr:description><gtr:id>61AFAC48-8F07-41FD-B340-669B7C6B77C8</gtr:id><gtr:impact>This collaboration has been integral to several grant successes, including applications to the Medical Research Council, British Heart Foundation the Department for Employment and Learning NI. Data using these animals and techniques has also provided the basis for recent grant applications, and has contributed to the following publications.

Ray R, Murdoch CE, Wang M, Santos CX, Zhang M, Alom-Ruiz S, Anilkumar N, Ouattara A, Cave AC, Walker SJ, Grieve DJ, Charles RL, Eaton P, Brewer AC, Shah AM. Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo. Arterioscler Thromb Vasc Biol 2011; 31: 1368-1376.

Zhao Y, McLaughlin D, Robinson E, Harvey AP, Hookham MB, Shah AM, McDermott BD, Grieve DJ. Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with doxorubicin chemotherapy. Cancer Res 2010; 70: 9287-9297.

Zhang M, Brewer AC, Schr&amp;ouml;der K, Santos CXC, Grieve DJ, Wang M, Anilkumar N, Yu B, Dong X, Walker SJ, Brandes RP, Shah AM. Nox4 NADPH oxidase mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis. Proc Natl Acad Sci USA 2010; 107: 18121-18126.

Looi YH, Grieve DJ, Siva A, Walker SJ, Anilkumar N, Cave AC, Marber M, Monaghan MJ, Shah AM. Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction. Hypertension 2008; 51: 319-325.

Momin A, Melikian N, Wheatcroft SB, Grieve D, John LC, El Gamel A, Marrinan MT, Desai JB, Driver C, Sherwood R, Shah AM, Kearney MT. The association between saphenous vein endothelial function, systemic inflammation, and statin therapy in patients undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg 2007; 134: 335-341.

Cave AC, Brewer AC, Narayanapanicker A, Ray R, Grieve DJ, Walker S, Shah AM. NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal 2006; 8: 691-728.

Johar S, Cave AC, Narayanapanicker A, Grieve DJ, Shah AM. Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase. FASEB J 2006; 20: 1546-1548.

Momin AU, Melikian N, Shah AM, Grieve DJ, Wheatcroft SB, John L, Gamel AE, Desai JB, Nelson T, Driver C, Sherwood RA, Kearney MT. Leptin is an endothelial-independent vasodilator in humans with coronary artery disease: evidence for tissue specificity of leptin resistance. Eur Heart J 2006; 27: 2294-2299.

Murdoch CE, Grieve DJ, Cave AC, Looi YH, Shah AM. NADPH oxidase and heart failure. Curr Opin Pharmacol 2006; 6: 148-153.

Grieve DJ, Byrne JA, Siva A, Layland J, Johar S, Cave AC, Shah AM. Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload. J Am Coll Cardiol 2006; 47: 817-826.</gtr:impact><gtr:outcomeId>750D08758F4-1</gtr:outcomeId><gtr:partnerContribution>Provision of experimental animals and teaching of laboratory analysis techniques.</gtr:partnerContribution><gtr:piContribution>Custom-made gene-modified animals have been kindly-provided which give a more novel aspect to our current studies. Highly skilled techniques such as cardiac fibroblast isolation/culture and quantification of matrix metalloproteinase activity which were acquired from King's College London are now in routine use in my laboratory and have significantly strengthened our research. Recently, KCL have kindly agreed to carry out a comprehensive proteomic analysis of cardiac tissue samples, which will complement microarray analysis conducted at QUB.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen's University Belfast</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Cancer Research and Cell Biology</gtr:department><gtr:description>CCRCB, Queen's University Belfast</gtr:description><gtr:id>899CD93F-695F-4A7E-A93D-8B6C80E6D7DB</gtr:id><gtr:impact>Expertise in this area will allow identification of candidate signalling pathways which are dysregulated in different situations. Expression of these genes can then be confirmed by real-time PCR and/or immunoblotting before embarking on more detailed in vitro experiments to identify precise mechanisms of action. This collaboration has formed part of several recent funding applications and is likely to become an increasingly important part of our research.</gtr:impact><gtr:outcomeId>83AE16C9F32-1</gtr:outcomeId><gtr:partnerContribution>Dr Dean Fennell routinely provides assistance with gene expression pathway analysis of profiling data obtained from our cardiac tissue samples.</gtr:partnerContribution><gtr:piContribution>Gene profiling has become an important analysis tool in our research. As we are not familiar with this technique, a team of scientists within the Centre for Cancer Research and Cell Biology at QUB routinely assist members of my laboratory with gene expression pathway analysis of data obtained from their samples.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Strathclyde</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Strathclyde Institute of Pharmacy &amp; Biomedical Sciences</gtr:department><gtr:description>University Of Strathclyde</gtr:description><gtr:id>DCB562AE-9573-47C5-924F-D3ED6C447A4E</gtr:id><gtr:impact>The most important outcome arising from this collaboration has been the sharing of resources and expertise for mutal benefit. To date, the following publication has arisen directly from this collaboration with another currently under revision.

Martin TP, Robinson E, Harvey AP, MacDonald MA, Grieve DJ, Paul A, Currie S. Surgical optimisation and characterisation of a minimally invasive aortic banding procedure to induce cardiac hypertrophy in mice. Exp Physiol 2012; 97: 822-832.</gtr:impact><gtr:outcomeId>fo3JzV8GekU-1</gtr:outcomeId><gtr:partnerContribution>This collaboration has resulted in the sharing of skills and expertise, particularly in relation to the techniques of in vivo thoracic aortic constriction and primary fibroblast isolation. One publication has arisen as a direct result of this collaboration and another is currently under review.</gtr:partnerContribution><gtr:piContribution>The post-doctoral fellow working on my MRC NIRG and then BHF PG/09/102/28133 taught the group in Strathclyde the technically-challenging prodecure of minimally-invasive thoracic aortic constriction. Our group has also contributed both functional and molecular characterisation data which will be used by Strathclyde as part of two important publications.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Trinity College Dublin</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:department>School of Medicine</gtr:department><gtr:description>University College Dublin</gtr:description><gtr:id>CC91EB51-5152-4DCE-B0DE-75C99C09063A</gtr:id><gtr:impact>Recently, I was a named collaborator on a funding application to the Health Reseach Board, Ireland, to which I contributed by significant expertise in experimental models of cardiovascular disease and their functional assessment.</gtr:impact><gtr:outcomeId>YfxmG9wH48v-1</gtr:outcomeId><gtr:partnerContribution>Projects are being largely driven by our collaboartors at UCD who are interested in inflammation and cardiovascular disease, with a particular emphasis on identification of novel biomarkers.</gtr:partnerContribution><gtr:piContribution>Further to acting as external examiner for PhD and MRes programmes at UCD, I have agreed to provide expertise in experimental models of cardiovascular disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Cardiovascular Science</gtr:department><gtr:description>University of Edinburgh</gtr:description><gtr:id>D4D609DF-F1B9-40C0-90E0-E9170670FCCB</gtr:id><gtr:impact>None to date.</gtr:impact><gtr:outcomeId>VoBo5opEty1-1</gtr:outcomeId><gtr:partnerContribution>Application of specialist expertise to our imaging system and research models.</gtr:partnerContribution><gtr:piContribution>Providing use of state-of-the-art imaging equipment and experimental studies for collaborative research study.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Press Release</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>616542AC-3FF1-4622-B126-7A8ABCC36B3A</gtr:id><gtr:impact>A press release was issued around our Cancer Research paper, funded by BHF PG/09/102/28133.

Local television, radio and newspaper interviews were conducted. Several articles were published in international publications e.g. BHF Heart Matters, Oncology News, aimed at both the general public and specialist audiences.</gtr:impact><gtr:outcomeId>XYsP2utmDyY</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.qub.ac.uk/home/ceao/News/ArchivedPressReleases/2011PressReleases/02-2011PressReleases/#d.en.224705</gtr:url><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MP Visits</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>EB6D291A-BA2F-4754-B8DB-2DE4F82BDC55</gtr:id><gtr:impact>Local Westminster MP's were invited to Queen's to be provided with information on animal research at the University. Three such visits have now taken place involving 4 MP's, at which I gave a semi-formal presentation and facilitated a tour of our animal facility.

Local MP's are now aware of the important animal -based biomedical research that we do at Queen's. They appear to be largely supportive, particularly in respect to the current issues around transportation of experimental animals. They are now also well informed ahead of the forhcoming Westminster debates relating to transposition of European Directive 2010/63/EU.</gtr:impact><gtr:outcomeId>nwcVrxadqmg</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BHF Staff Visit 2011</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>2C9C36EB-0FBA-4CD7-B004-0FF01B5D388C</gtr:id><gtr:impact>Approximately 10 local British Heart Foundation staff visited our research centre. Researchers, including myself, gave presentations targeted at this lay audience followed by a tour of our laboratory facilities.

This visit has increased local awareness and interest in our research and will significantly help the BHF staff when they are carrying out their fundraising and public information activities.</gtr:impact><gtr:outcomeId>G9w36up8Jeu</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>215708</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British Heart Foundation Project Grant</gtr:description><gtr:end>2014-05-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>PG/09/102/28133</gtr:fundingRef><gtr:id>763F101A-3095-465B-BAFA-406283F8DF9C</gtr:id><gtr:outcomeId>KpQwMMyJ2Yg0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50456</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Department for Employment and Learning Northern Ireland (DELNI)</gtr:department><gtr:description>DELNI PhD Studentship 2008</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Government of Northern Ireland</gtr:fundingOrg><gtr:id>71FDE7C8-68AE-4039-B3AC-C365695D4E90</gtr:id><gtr:outcomeId>LfB9DVS9ppW</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50456</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Department for Employment and Learning Northern Ireland (DELNI)</gtr:department><gtr:description>DELNI PhD Studentship 2009</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Government of Northern Ireland</gtr:fundingOrg><gtr:id>4255CB6D-87ED-44EB-968F-3A0130DB2FB5</gtr:id><gtr:outcomeId>B335FFD8AFD0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>This novel mouse line was produced by crossing commercially-available PPAR-alpha and Nox2 knockout mice over several generations. The line is viable and fertile and tolerates anaesthesia and surgery without complication.</gtr:description><gtr:id>23B10A02-F20E-49B7-B169-FA8681489B7A</gtr:id><gtr:impact>As far as we are aware, no other research groups are currently studying this model. As such it will provide a novel tool to further investigate the complex relationship between PPAR-alpha and Nox2 during the development and progression of cardiac remodeling. Indeed, preliminary data indicates an interesting response to chronic pressure-overload which may help to understand detailed underlying mechanisms.</gtr:impact><gtr:outcomeId>KfuTQGqYwoM</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>PPAR-alpha/Nox2 double knockout mouse</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The minimally-invasive technique for the induction of chronic pressure-overload by tranverse aortic constriction has been developed in our laboratory. This has replaced the previously employed invasive models of abdominal and thoracic aortic constriction.</gtr:description><gtr:id>7BD06630-1D89-488F-A659-94B2A80C5E49</gtr:id><gtr:impact>This model is much less traumatic for the animal and it negates the need for thoractomy or laparotomy. It is more efficient in terms of time and resources and leads to a more consistent development of chronic pressure-overload and cardiac hypertrophy. Establishment of this model formed the basis of an ongoing collaboration with the University of Strathclyde and the following publications.

Martin TP, Robinson E, Harvey AP, MacDonald MA, Grieve DJ, Paul A, Currie S. Surgical optimisation and characterisation of a minimally invasive aortic banding procedure to induce cardiac hypertrophy in mice. Exp Physiol 2012; 97: 822-832.

Martin TP, Lawan A, Robinson E, Grieve DJ, Plevin R, Paul A, Currie S. Adult cardiac fibroblast proliferation is modulated by calcium/calmodulin-dependent protein kinase II in normal and hypertrophied hearts. Pflugers Arch 2013 Jul 24. [Epub ahead of print]

It has also been shared with collaborators at University College Dublin where the model is now established.</gtr:impact><gtr:outcomeId>DEC8C971F9B</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Thoracic aortic constriction</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>This state-of-the-art technology builds upon previously employed cardiac pressure-volume systems to provide true volumes in real-time, circumventing the need for cumbersome and inaccurate calibrations.</gtr:description><gtr:id>60D4185E-E9A6-4892-B952-62E5E463F642</gtr:id><gtr:impact>This technology makes our functional data much more reliable as it circumvents potential inaccuracies due to calibration errors secondary to changes in myocardial conductance through the cardiac cycle. It also overcomes problems encountered by chamber assymetry and the morphological changes associated with cardiac remodelling.</gtr:impact><gtr:outcomeId>7EC3C31E302</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Admittance-based measurement of cardiac pressure-volume relations</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>4B0FB86F-325E-48F0-80BD-41415F307811</gtr:id><gtr:title>The gastrointestinal peptide obestatin induces vascular relaxation via specific activation of endothelium-dependent NO signalling.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33771eb123dbc251132fbde6b1e478ef"><gtr:id>33771eb123dbc251132fbde6b1e478ef</gtr:id><gtr:otherNames>Agnew AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>pm_12636_26_22035179</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E794BCE3-CBCA-45D9-9574-F7832FBB1A89</gtr:id><gtr:title>INVESTIGATION OF MECHANISMS UNDERLYING THE INTERACTION BETWEEN NOX2 NADPH OXIDASE AND PPAR-a IN LEFT VENTRICULAR HYPERTROPHY</gtr:title><gtr:parentPublicationTitle>Heart</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81eaece4c9ca746be88b722aa99a6962"><gtr:id>81eaece4c9ca746be88b722aa99a6962</gtr:id><gtr:otherNames>Harvey A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>58ca9abc2386b2.49029746</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9989958-C865-432F-AF0A-FF62C275892A</gtr:id><gtr:title>Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction.</gtr:title><gtr:parentPublicationTitle>Hypertension (Dallas, Tex. : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6a0da37bd041bfabc51ddc8cc99b694"><gtr:id>e6a0da37bd041bfabc51ddc8cc99b694</gtr:id><gtr:otherNames>Looi YH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0194-911X</gtr:issn><gtr:outcomeId>pm_12636_16_18180403</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1ADE384D-1BA4-41BD-8632-A89AFECAF12A</gtr:id><gtr:title>Interaction between peroxisome proliferator-activated receptor-a and NADPH oxidases plays an important role in the development of pressure-overload cardiac hypertrophy</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe29cc661306d654b9abacc95dc33bae"><gtr:id>fe29cc661306d654b9abacc95dc33bae</gtr:id><gtr:otherNames>Robinson E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>58ca57bf7d8445.65958816</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>639AA2A4-DBD7-4E96-A193-4A46AF656752</gtr:id><gtr:title>NADPH Oxidase-4 Driven Cardiac Macrophage Polarization Protects Against Myocardial Infarction-Induced Remodeling.</gtr:title><gtr:parentPublicationTitle>JACC. Basic to translational science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a00e398f8b142d3e979ff98ea09b447"><gtr:id>0a00e398f8b142d3e979ff98ea09b447</gtr:id><gtr:otherNames>Mongue-Din H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2452-302X</gtr:issn><gtr:outcomeId>5a9d4e15f179f5.75353049</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2FDA8915-A1D9-4624-B650-6BDB31ECFA1C</gtr:id><gtr:title>Conformational change of mitochondrial complex I increases ROS sensitivity during ischemia.</gtr:title><gtr:parentPublicationTitle>Antioxidants &amp; redox signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bee28fd3e63a48677516ba5a9e27ecf9"><gtr:id>bee28fd3e63a48677516ba5a9e27ecf9</gtr:id><gtr:otherNames>Gorenkova N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1523-0864</gtr:issn><gtr:outcomeId>pm_12636_26_23419200</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6262FA31-D5F6-4659-983C-83DBEB8CC115</gtr:id><gtr:title>The association between saphenous vein endothelial function, systemic inflammation, and statin therapy in patients undergoing coronary artery bypass surgery.</gtr:title><gtr:parentPublicationTitle>The Journal of thoracic and cardiovascular surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9fb1de09bc3a0f6c74166f4997a9cab2"><gtr:id>9fb1de09bc3a0f6c74166f4997a9cab2</gtr:id><gtr:otherNames>Momin A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-5223</gtr:issn><gtr:outcomeId>pm_12636_16_17662770</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA288943-C7BB-40FF-B710-2C9E296AD85B</gtr:id><gtr:title>Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control?</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09ca16a2b53ba31a02e9577ca9e67033"><gtr:id>09ca16a2b53ba31a02e9577ca9e67033</gtr:id><gtr:otherNames>Grieve DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>pm_12636_16_19681866</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1CEEDB23-091F-4DE4-A401-1E6607FAD93C</gtr:id><gtr:title>Systems Biology of Free Radicals and Antioxidants</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81eaece4c9ca746be88b722aa99a6962"><gtr:id>81eaece4c9ca746be88b722aa99a6962</gtr:id><gtr:otherNames>Harvey A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:isbn>978-3-642-30017-2</gtr:isbn><gtr:outcomeId>5458d3ae29f298.72383662</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>662CC297-CE1E-474E-BA6A-ED94CAA7568B</gtr:id><gtr:title>Metabolically-inactive glucagon-like peptide-1(9-36)amide confers selective protective actions against post-myocardial infarction remodelling.</gtr:title><gtr:parentPublicationTitle>Cardiovascular diabetology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe29cc661306d654b9abacc95dc33bae"><gtr:id>fe29cc661306d654b9abacc95dc33bae</gtr:id><gtr:otherNames>Robinson E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1475-2840</gtr:issn><gtr:outcomeId>585d50ad631ea4.91473723</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A43CF85-01CB-4CC5-8938-6CFEB61F21D5</gtr:id><gtr:title>Surgical optimization and characterization of a minimally invasive aortic banding procedure to induce cardiac hypertrophy in mice.</gtr:title><gtr:parentPublicationTitle>Experimental physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/485fd267fefa682a0d793791a80149d2"><gtr:id>485fd267fefa682a0d793791a80149d2</gtr:id><gtr:otherNames>Martin TP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0958-0670</gtr:issn><gtr:outcomeId>pm_12636_26_22447975</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDC99D7E-BC7A-45C1-9166-F5728725A323</gtr:id><gtr:title>38 Does interaction between peroxisome proliferator-activated receptor-&amp;nbsp; and NADPH oxidases play an important role in regulating pressure-overload cardiac hypertrophy?</gtr:title><gtr:parentPublicationTitle>Heart</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81eaece4c9ca746be88b722aa99a6962"><gtr:id>81eaece4c9ca746be88b722aa99a6962</gtr:id><gtr:otherNames>Harvey A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>58ca59cdbd1cc1.14458759</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6188547-2B69-47B5-95C2-75500780D6B2</gtr:id><gtr:title>BAS/BSCR25 Importance of interaction between peroxisome proliferator-activated receptor-&amp;nbsp; and NADPH oxidases in cardiac hypertrophy</gtr:title><gtr:parentPublicationTitle>Heart</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe29cc661306d654b9abacc95dc33bae"><gtr:id>fe29cc661306d654b9abacc95dc33bae</gtr:id><gtr:otherNames>Robinson E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>58ca58cc42f234.37497647</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F8C8D71-1DCD-4667-B9ED-943B462B89F2</gtr:id><gtr:title>Exendin-4 attenuates adverse cardiac remodelling in streptozocin-induced diabetes via specific actions on infiltrating macrophages.</gtr:title><gtr:parentPublicationTitle>Basic research in cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c3246c4918366055322ea1064954082"><gtr:id>2c3246c4918366055322ea1064954082</gtr:id><gtr:otherNames>Tate M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0300-8428</gtr:issn><gtr:outcomeId>56d97dc741cf08.83730382</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B92EFEA8-55FC-4CEF-9383-CD96F14A00DC</gtr:id><gtr:title>Selective targeting of glucagon-like peptide-1 signalling as a novel therapeutic approach for cardiovascular disease in diabetes.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c3246c4918366055322ea1064954082"><gtr:id>2c3246c4918366055322ea1064954082</gtr:id><gtr:otherNames>Tate M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>5458d268e63459.27804263</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EADDA952-8CCA-4A08-B322-26B618C3D6D5</gtr:id><gtr:title>Adult cardiac fibroblast proliferation is modulated by calcium/calmodulin-dependent protein kinase II in normal and hypertrophied hearts.</gtr:title><gtr:parentPublicationTitle>Pflugers Archiv : European journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/485fd267fefa682a0d793791a80149d2"><gtr:id>485fd267fefa682a0d793791a80149d2</gtr:id><gtr:otherNames>Martin TP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0031-6768</gtr:issn><gtr:outcomeId>pm_12636_26_23881186</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73D90825-61D5-472E-9B96-231CEDD0B3B1</gtr:id><gtr:title>Cross-talk between NADPH oxidases and peroxisome proliferator activated receptor- alpha differentially regulates left ventricular hypertrophy via specific activation of key signalling pathways</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8af6a15375f0e1a8e32a8a0dd91d37a3"><gtr:id>8af6a15375f0e1a8e32a8a0dd91d37a3</gtr:id><gtr:otherNames>Harvey AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>58caa654070838.51979302</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6668ECA-DA79-4671-B948-5A7EC5B20C02</gtr:id><gtr:title>PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-a AND NADPH OXIDASES INTERACT TO PLAY AN IMPORTANT REGULATORY ROLE IN PRESSURE-OVERLOAD CARDIAC HYPERTROPHY</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8af6a15375f0e1a8e32a8a0dd91d37a3"><gtr:id>8af6a15375f0e1a8e32a8a0dd91d37a3</gtr:id><gtr:otherNames>Harvey AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>58ca9812863a92.93218935</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4955C3A3-0B4A-4F67-9C42-9B999CEFFAD8</gtr:id><gtr:title>Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with Doxorubicin chemotherapy.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/673680106ade3187f249d2a683028495"><gtr:id>673680106ade3187f249d2a683028495</gtr:id><gtr:otherNames>Zhao Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>pm_12636_26_20884632</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D94B35A-122D-40A6-BF07-21E5FB6C55D7</gtr:id><gtr:title>New insights into cardiotoxicity caused by chemotherapeutic agents.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09ca16a2b53ba31a02e9577ca9e67033"><gtr:id>09ca16a2b53ba31a02e9577ca9e67033</gtr:id><gtr:otherNames>Grieve DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>5a9d4e16d42479.26439975</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0BE5098E-5A1E-46F7-ACC9-342097917ED5</gtr:id><gtr:title>Signalling mechanisms underlying doxorubicin and Nox2 NADPH oxidase-induced cardiomyopathy: involvement of mitofusin-2.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf22be1e2d0e1ddf2ab595e66bfe82d6"><gtr:id>cf22be1e2d0e1ddf2ab595e66bfe82d6</gtr:id><gtr:otherNames>McLaughlin D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>58cafda9668946.46703833</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D47E684F-53BC-4360-826E-A8B54D36F103</gtr:id><gtr:title>42 Identification of an inherent mechanism of NADPH oxidase signalling in doxorubicin cardiotoxicity</gtr:title><gtr:parentPublicationTitle>Heart</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf22be1e2d0e1ddf2ab595e66bfe82d6"><gtr:id>cf22be1e2d0e1ddf2ab595e66bfe82d6</gtr:id><gtr:otherNames>McLaughlin D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>58ca5a87cbaa47.32065482</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>53EB2930-39B4-418E-BFD5-6E3CB0CEAEDF</gtr:id><gtr:title>Exendin-4 protects against post-myocardial infarction remodelling via specific actions on inflammation and the extracellular matrix.</gtr:title><gtr:parentPublicationTitle>Basic research in cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe29cc661306d654b9abacc95dc33bae"><gtr:id>fe29cc661306d654b9abacc95dc33bae</gtr:id><gtr:otherNames>Robinson E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0300-8428</gtr:issn><gtr:outcomeId>doi_55f98498416242ef</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D9522B8-DE1F-4CBA-9C21-398BE1A80EA8</gtr:id><gtr:title>Significance of peroxisome proliferator-activated receptors in the cardiovascular system in health and disease.</gtr:title><gtr:parentPublicationTitle>Pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe29cc661306d654b9abacc95dc33bae"><gtr:id>fe29cc661306d654b9abacc95dc33bae</gtr:id><gtr:otherNames>Robinson E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0163-7258</gtr:issn><gtr:outcomeId>pm_12636_16_19318113</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23039C81-7A1C-4093-B536-1CF9899579F8</gtr:id><gtr:title>GLP-1 and related peptides cause concentration-dependent relaxation of rat aorta through a pathway involving KATP and cAMP.</gtr:title><gtr:parentPublicationTitle>Archives of biochemistry and biophysics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d06788fb831a564baa6694ea32bdacfd"><gtr:id>d06788fb831a564baa6694ea32bdacfd</gtr:id><gtr:otherNames>Green BD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0003-9861</gtr:issn><gtr:outcomeId>pm_12636_16_18708025</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0601215</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>